Drugs

Monroe Capital provides USD27m for Collaborative Neuroscience Network ESOP transaction

Monroe Capital has provided a USD27m unitranche facility to support the sale of Collaborative Neuroscience Network (CNS Network) to a 100 per cent Employee Stock Ownership Plan (ESOP) owned corporation.

This is the first transaction completed by Monroe Capital’s newly-formed national ESOP lending practice.

ESOPs offer corporate and individual level tax advantages that are not typically available in traditional third party sales. In today’s rising tax rate environment, Monroe Capital anticipates that demand will be robust for similarly structured ESOP transactions in 2013 and beyond.

Based in Garden Grove, California, CNS Network is a clinical trial research provider, assisting pharmaceutical companies and contract research organisations with the various phases of drug development. The company provides services that manage various aspects of clinical trials for pharmaceutical companies testing potential compounds and drugs for FDA approval.

Further reading



Upcoming events

Upcoming training

Mon, 10/11/2014 (All day) - London
Mon, 10/11/2014 (All day) - London
Thu, 13/11/2014 (All day) - London